Publications by authors named "Furer N"

Article Synopsis
  • RNA splicing factors often mutate in blood disorders like myelodysplastic syndrome (MDS), affecting how blood cells develop, but the role of these mutations in blood formation is still not fully understood.
  • Researchers used a new method, GoT-Splice, which combines gene profiling and advanced single-cell analysis to study how mutations in a specific splicing factor (SF3B1) influence blood progenitor cells.
  • Their findings showed that SF3B1 mutations lead to abnormal splicing patterns and an increase in specific blood cell types before MDS is clinically evident, highlighting the importance of understanding these mutations in early disease progression.
View Article and Find Full Text PDF

Deep targeted sequencing technologies are still not widely used in clinical practice due to the complexity of the methods and their cost. The Molecular Inversion Probes (MIP) technology is cost effective and scalable in the number of targets, however, suffers from low overall performance especially in GC rich regions. In order to improve the MIP performance, we sequenced a large cohort of healthy individuals ( = 4417), with a panel of 616 MIPs, at high depth in duplicates.

View Article and Find Full Text PDF

High efficacy of prodigiozan, a bacterial polysaccharide used in the form of inhalation in combined therapy of 123 children at the age of 3 to 14 with nonspecific bronchopulmonary pathologic conditions was shown. The drug was administered by means of inhalators UI-I and PAI-I once every 4--5 days in the form of 0.02 per cent solution prepared in situ.

View Article and Find Full Text PDF

For prophylaxis influenza in the infection foci under stationary conditions 213 children were treated with leucocytic interferon with metacyl and 192 children were observed as the control group. The drug was administered intranasally in a dose of 0.25 ml once a day.

View Article and Find Full Text PDF